Literature DB >> 14745501

Nucleotide-binding domains of human cystic fibrosis transmembrane conductance regulator: detailed sequence analysis and three-dimensional modeling of the heterodimer.

I Callebaut1, R Eudes, J-P Mornon, P Lehn.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) protein is encoded by the gene that is defective in cystic fibrosis, the most common lethal inherited disease among the Caucasian population. CFTR belongs to the ABC transporter superfamily, whose members form macromolecular architectures composed of two membrane-spanning domains and two nucleotide-binding domains (NBDs). The experimental structures of NBDs from several ABC transporters have recently been solved, opening new avenues for understanding the structure/function relationships and the consequences of some disease-causing mutations of CFTR. Based on a detailed sequence/structure analysis, we propose here a three-dimensional model of the human CFTR NBD heterodimer. This model, which is in agreement with recent experimental data, highlights the specific features of the CFTR asymmetric active sites located at the interface between the two NBDs. Moreover, additional CFTR-specific features can be identified at the subunit interface, which may play critical roles in active site interdependence and are uncommon in other NBD dimers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745501     DOI: 10.1007/s00018-003-3386-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  6 in total

1.  Images in cardiovascular medicine. Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging.

Authors:  Luis J J Borreguero; Roberto Corti; Rafael F de Soria; Julio I Osende; Valentin Fuster; Juan J Badimon
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

Review 2.  Noncompaction of the ventricular myocardium.

Authors:  Brian C Weiford; Vijay D Subbarao; Kevin M Mulhern
Journal:  Circulation       Date:  2004-06-22       Impact factor: 29.690

3.  Noncompaction of the left ventricle in a patient with dextroversion.

Authors:  Mark A Friedman; Sampson Wiseman; Linda Haramati; Garet M Gordon; Daniel M Spevack
Journal:  Eur J Echocardiogr       Date:  2006-02-28

4.  Biventricular noncompaction in a patient with dextrocardia/dextroversion diagnosed with cardiac magnetic resonance imaging.

Authors:  Michael J Grattan; Ilan Buffo-Sequeira; Marielle Fortier; Dionissios Pepelassis
Journal:  Can J Cardiol       Date:  2009-09       Impact factor: 5.223

5.  Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy.

Authors:  R Jenni; E Oechslin; J Schneider; C Attenhofer Jost; P A Kaufmann
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

6.  Angiographic diagnosis, prevalence and outcomes for left ventricular noncompaction in children with congenital cardiac disease.

Authors:  Marina L Hughes; Bendix Carstensen; James L Wilkinson; Robert G Weintraub
Journal:  Cardiol Young       Date:  2006-12-22       Impact factor: 1.093

  6 in total
  17 in total

1.  C terminus of nucleotide binding domain 1 contains critical features for cystic fibrosis transmembrane conductance regulator trafficking and activation.

Authors:  Arnaud Billet; Patricia Melin; Mathilde Jollivet; Jean-Paul Mornon; Isabelle Callebaut; Frédéric Becq
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

2.  Attempts to characterize the NBD heterodimer of MRP1: transient complex formation involves Gly771 of the ABC signature sequence but does not enhance the intrinsic ATPase activity.

Authors:  Odile Ramaen; Christina Sizun; Olivier Pamlard; Eric Jacquet; Jean-Yves Lallemand
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

3.  The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.

Authors:  Fiona L L Stratford; Mohabir Ramjeesingh; Joanne C Cheung; Ling-Jun Huan; Christine E Bear
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

4.  The glycine residues G551 and G1349 within the ATP-binding cassette signature motifs play critical roles in the activation and inhibition of cystic fibrosis transmembrane conductance regulator channels by phloxine B.

Authors:  Patricia Melin; Caroline Norez; Isabelle Callebaut; Frédéric Becq
Journal:  J Membr Biol       Date:  2006-04-07       Impact factor: 1.843

5.  Molecular models of the open and closed states of the whole human CFTR protein.

Authors:  Jean-Paul Mornon; Pierre Lehn; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

Review 6.  Cystic fibrosis transmembrane conductance regulator (ABCC7) structure.

Authors:  John F Hunt; Chi Wang; Robert C Ford
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

Review 7.  Role of CFTR's intrinsic adenylate kinase activity in gating of the Cl(-) channel.

Authors:  Christoph O Randak; Michael J Welsh
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

8.  Full-open and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics.

Authors:  Jean-Paul Mornon; Brice Hoffmann; Slavica Jonic; Pierre Lehn; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2014-10-07       Impact factor: 9.261

9.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

10.  Characterization of non-trivial neighborhood fold constraints from protein sequences using generalized topohydrophobicity.

Authors:  Guillaume Fourty; Isabelle Callebaut; Jean-Paul Mornon
Journal:  Bioinform Biol Insights       Date:  2008-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.